Testing for COVID-19: Increasing testing supply

On this page

What Canada is doing

Canada is mobilizing industry and providing support for research, market approval, manufacturing and access to medical supplies. We're working proactively with companies that are developing new and innovative testing technologies. We're also engaging with international regulators to share knowledge about new developments related to testing.

Increasing testing options

Health Canada reviews testing devices to assess their safety, effectiveness and quality before they're authorized for sale in Canada. For a test to be authorized by Health Canada, it must be submitted for review by the manufacturer. To date, Health Canada has authorized over 50 different COVID-19 tests. We also continue to expedite the review of COVID-19 tests, including new testing options.

Health Canada is currently prioritizing the review of:

Health Canada has received a number of antigen test applications that are under priority review. Antigen tests detect specific proteins on the surface of the virus and provide rapid results.

A small number of saliva tests have been submitted to Health Canada and are under priority review. Health Canada hasn't authorized any tests for use with saliva at this time.

Health Canada will expedite the review of any new testing technologies submitted by manufacturers, including at-home test kits (also known as "self-testing"). For at-home test kits, the manufacturer must provide data to show the test is safe and effective for Canadians to use without health care professional supervision.

In all cases, companies must provide evidence that the test is accurate and reliable before Health Canada will authorize it. Health Canada has provided guidance to manufacturers on the authorization requirements for different types of tests such as antibody tests and antigen tests.

Rapid tests distributed in Canada

The Government of Canada has purchased over 40 million units of the following rapid tests:

The tables below show the number of COVID-19 rapid tests that have been shipped in provinces and territories as of April 8, 2021 (deployment data as of April 6, 2021). The data for tests deployed show the quantities of rapid tests that have been distributed to their final point-of-care setting where they will be administered to patients. These data do not show how many rapid tests have been used. 

There is a delay in the reporting on the deployment of rapid tests. This is due to the time when tests are:

The numbers listed are updated once a week.

Canada
Distribution of tests in Canada
Product name Tests shipped Tests deployedFootnote *
Abbott ID Now 6,507,024 1,138,836
Abbott Panbio 22,895,450 8,328,729
BD Veritor 11,599,980 1,094,238
Quidel Sofia 850,000 0
Total 41,852,454 10,561,803
Footnote 1

The test deployed information show the number of tests that have been distributed to their final point-of-care setting where they will be administered to patients. These numbers do not show how many tests have been used.

Return to footnote * referrer

Newfoundland and Labrador
Distribution of tests for Newfoundland and Labrador
Product name Tests shipped Tests deployedFootnote *
Abbott ID Now 85,432 63,168
Abbott Panbio 304,200 260,375
BD Veritor 0 0
Total 389,632 323,543
Footnote 1

The test deployed information show the number of tests that have been distributed to their final point-of-care setting where they will be administered to patients. These numbers do not show how many tests have been used.

Return to footnote * referrer

Prince Edward Island
Distribution of tests for Prince Edward Island
Product name Tests shipped Tests deployedFootnote *
Abbott ID Now 11,328 6,416
Abbott Panbio 26,400 no information provided
BD Veritor 0 0
Total 37,728 6,416
Footnote 1

The test deployed information show the number of tests that have been distributed to their final point-of-care setting where they will be administered to patients. These numbers do not show how many tests have been used.

Return to footnote * referrer

Nova Scotia
Distribution of tests for Nova Scotia
Product name Tests shipped Tests deployedFootnote *
Abbott ID Now 106,512 no information provided
Abbott Panbio 318,825 26,293
BD Veritor 110,160 1,664
Total 535,497 27,957
Footnote 1

The test deployed information show the number of tests that have been distributed to their final point-of-care setting where they will be administered to patients. These numbers do not show how many tests have been used.

Return to footnote * referrer

New Brunswick
Distribution of tests for New Brunswick
Product name Tests shipped Tests deployedFootnote *
Abbott ID Now 78,912 11,808
Abbott Panbio 320,800 17,150
BD Veritor 0 0
Total 399,712 28,958
Footnote 1

The test deployed information show the number of tests that have been distributed to their final point-of-care setting where they will be administered to patients. These numbers do not show how many tests have been used.

Return to footnote * referrer

Quebec
Distribution of tests for Quebec
Product name Tests shipped Tests deployedFootnote *
Abbott ID Now 822,816 420,384
Abbott Panbio 3,063,750 1,103,600
BD Veritor 911,280 359,700
Total 4,797,846 1,883,684
Footnote 1

The test deployed information show the number of tests that have been distributed to their final point-of-care setting where they will be administered to patients. These numbers do not show how many tests have been used.

Return to footnote * referrer

Ontario
Distribution of tests for Ontario
Product name Tests shipped Tests deployedFootnote *
Abbott ID Now 1,218,144 236,683
Abbott Panbio 6,928,588 5,276,305
BD Veritor 2,864,160 71,138
Quidel Sofia 73,200 0
Total 11,084,092 5,584,126
Footnote 1

The test deployed information show the number of tests that have been distributed to their final point-of-care setting where they will be administered to patients. These numbers do not show how many tests have been used.

Return to footnote * referrer

Manitoba
Distribution of tests for Manitoba
Product name Tests shipped Tests deployedFootnote *
Abbott ID Now 176,448 9,020
Abbott Panbio 558,400 18,300
BD Veritor 194,400 1,170
Total 929,248 28,490
Footnote 1

The test deployed information show the number of tests that have been distributed to their final point-of-care setting where they will be administered to patients. These numbers do not show how many tests have been used.

Return to footnote * referrer

Saskatchewan
Distribution of tests for Saskwatchewan
Product name Tests shipped Tests deployedFootnote *
Abbott ID Now 148,416 59,347
Abbott Panbio 1,024,800 414,548
BD Veritor 142,560 0
Total 1,315,776 473,895
Footnote 1

The test deployed information show the number of tests that have been distributed to their final point-of-care setting where they will be administered to patients. These numbers do not show how many tests have been used.

Return to footnote * referrer

Alberta
Distribution of tests for Alberta
Product name Tests shipped Tests deployedFootnote *
Abbott ID Now 537,912 162,108
Abbott Panbio 1,785,600 713,058
BD Veritor 613,440 641,126
Total 2,936,952 1,516,292
Footnote 1

The test deployed information show the number of tests that have been distributed to their final point-of-care setting where they will be administered to patients. These numbers do not show how many tests have been used.

Return to footnote * referrer

British Columbia
Distribution of tests for British Columbia
Product name Tests shipped Tests deployedFootnote *
Abbott ID Now 626,976 51,360
Abbott Panbio 1,779,650 296,600
BD Veritor 389,880 9,360
Total 2,796,506 357,320
Footnote 1

The test deployed information show the number of tests that have been distributed to their final point-of-care setting where they will be administered to patients. These numbers do not show how many tests have been used.

Return to footnote * referrer

Yukon
Distribution of tests for Yukon
Product name Tests shipped Tests deployedFootnote *
Abbott ID Now 15,720 no information provided
Abbott Panbio 13,600 no information provided
BD Veritor 0 0
Total 29,320 0
Footnote 1

The test deployed information show the number of tests that have been distributed to their final point-of-care setting where they will be administered to patients. These numbers do not show how many tests have been used.

Return to footnote * referrer

Northwest Territories
Distribution of tests for Northwest Territories
Product name Tests shipped Tests deployedFootnote *
Abbott ID Now 16,728 4,512
Abbott Panbio 12,800 3,825
BD Veritor 0 0
Total 29,528 8,337
Footnote 1

The test deployed information show the number of tests that have been distributed to their final point-of-care setting where they will be administered to patients. These numbers do not show how many tests have been used.

Return to footnote * referrer

Nunavut
Distribution of tests for Nunavut
Product name Tests shipped Tests deployedFootnote *
Abbott ID Now 15,720 2,550
Abbott Panbio 22,400 4,800
BD Veritor 0 0
Total 38,120 7,350
Footnote 1

The test deployed information show the number of tests that have been distributed to their final point-of-care setting where they will be administered to patients. These numbers do not show how many tests have been used.

Return to footnote * referrer

Federal allocation
Distribution of tests for Federal allocationFootnote *
Product name Tests shipped Tests deployedFootnote **
Abbott ID Now 2,645,960 111,480
Abbott Panbio 6,735,637 193,875
BD Veritor 6,374,100 10,080
Quidel Sofia 776,800 0
Total 16,532,497 315,435
Footnote *

The federal numbers include tests distributed to the Department of National Defence (DND), Correctional Services Canada (CSC), the Public Health Agency of Canada (PHAC), as well as Northern, remote and Indigenous communities.

Return to footnote * referrer

Footnote **

The test deployed information show the number of tests that have been distributed to their final point-of-care setting where they will be administered to patients. These numbers do not show how many tests have been used.

Return to footnote ** referrer

Supporting provincial and territorial COVID-19 testing capacity

The federal government is providing $4.28 billion to the provinces and territories. This money is to help them conduct testing, perform contact tracing and share public health data that will help fight the pandemic. The goal is to ensure they have the capacity to test up to 200,000 people each day, nationwide.

Canada is also providing funding and support to improve and modernize data management across Canada. This support is to help all levels of government coordinate their efforts to contain the virus.

The table below shows the current capacity for each province and territory compared to the capacity target agreed to under the Safe Restart Agreement.

The national capacity target of about 200,000 tests each day is based on modelling. This modelling exercise indicates this capacity is enough to meet the expected demand for testing.

Provincial and territorial COVID-19 testing capacity

Testing capacity reported as of April 8, 2021.

Please consult the Coronavirus disease 2019 (COVID-19): Epidemiology update for daily and weekly updates on the average number of people tested.

In circumstances where capacity was not reported, the previous week's capacity was indicated (see *).

Newfoundland and Labrador: Target 2,500 - 3,000
COVID-19 testing capacity for Newfoundland and Labrador (Target 2,500 - 3,000Footnote***)
Date Projected daily maximum testing capacity
2020-09-03 1,450
2020-09-10 1,450
2020-09-17 1,450
2020-09-24 1,450
2020-10-01 1,450
2020-10-08 1,450
2020-10-15 1,450
2020-10-22 1,450
2020-10-29 1,450
2020-11-03 1,450
2020-11-10 1,450
2020-11-17 1,450
2020-11-24 1,450
2020-12-01 1,450
2020-12-08 1,450
2020-12-15 1,450
2020-12-22 1,450
2020-12-29 1,450
2021-01-05 1,450
2021-01-12 1,450
2021-01-19 1,450
2021-01-26 1,450
2021-02-02 1,450
2021-02-09 1,700
2021-02-16 1,700Footnote *
2021-02-23 1,700
2021-03-02 1,700
2021-03-09 1,700
2021-03-16 1,700
2021-03-23 2,100
2021-03-29 2,100
2021-04-06 2,100
Footnote ***

Target updated October 6 at the request of Newfoundland and Labrador

Return to footnote*** referrer

Prince Edward Island: Target 835
COVID-19 testing capacity for Prince Edward Island (Target 835)
Date Projected daily maximum testing capacity
2020-09-03 350
2020-09-10 430
2020-09-17 350
2020-09-24 350
2020-10-01 400
2020-10-08 400
2020-10-15 400 (800Footnote**)
2020-10-22 400 (800Footnote**)
2020-10-29 400 (800Footnote**)
2020-11-03 400 (800Footnote**)
2020-11-10 400 (800Footnote**)
2020-11-17 400 (800Footnote**)
2020-11-24 400 (800Footnote**)
2020-12-01 400 (800Footnote**)
2020-12-08 400Footnote* (800Footnote**)
2020-12-15 400 (800Footnote**)
2020-12-22 400
2020-12-29 400
2021-01-05 600
2021-01-12 600
2021-01-19 600
2021-01-26 600
2021-02-02 700
2021-02-09 850
2021-02-16 850
2021-02-23 850
2021-03-02 850
2021-03-09 850
2021-03-16 850
2021-03-23 850
2021-03-29 850
2021-04-06 850
Footnote **

Revised to include the surge testing capacity available on a temporary basis.

Return to footnote** referrer

Nova Scotia: Target 2,500
COVID-19 testing capacity for Nova Scotia (Target 2,500)
Date Projected daily maximum testing capacity
2020-09-03 1,500
2020-09-10 1,500
2020-09-17 1,500
2020-09-24 1,500
2020-10-01 1,500
2020-10-08 1,500
2020-10-15 1,500
2020-10-22 1,500
2020-10-29 1,500
2020-11-03 1,500
2020-11-10 1,500
2020-11-17 1,500
2020-11-24 2,500
2020-12-01 2,500
2020-12-08 2,500
2020-12-15 2,500
2020-12-22 2,500
2020-12-29 2,500
2021-01-05 2,500
2021-01-12 2,500
2021-01-19 2,500
2021-01-26 2,500
2021-02-02 2,500
2021-02-09 2,500
2021-02-16 2,500
2021-02-23 2,500
2021-03-02 2,500
2021-03-09 2,500
2021-03-16 2,500
2021-03-23 2,500
2021-03-29 2,500
2021-04-06 2,500
New Brunswick: Target 2,500 - 3,000
COVID-19 testing capacity for New Brunswick (Target 2,500 - 3,000)
Date Projected daily maximum testing capacity
2020-09-03 1,500
2020-09-10 1,500
2020-09-17 1,500
2020-09-24 1,500
2020-10-01 1,500
2020-10-08 1,500
2020-10-15 1,500
2020-10-22 1,500
2020-10-29 2,000
2020-11-03 2,000
2020-11-10 2,000
2020-11-17 2,000
2020-11-24 2,000Footnote*
2020-12-01 2,000
2020-12-08 2,000Footnote*
2020-12-15 2,500
2020-12-22 2,500
2020-12-29 2,500
2021-01-05 2,500
2021-01-12 2,000
2021-01-19 2,000
2021-01-26 2,000
2021-02-02 2,000
2021-02-09 3,000
2021-02-16 3,000
2021-02-23 3,000
2021-03-02 3,000
2021-03-09 3,000
2021-03-16 3,000
2021-03-23 3,000
2021-03-29 3,000
2021-04-06 3,000
Quebec: Target 35,000
COVID-19 testing capacity for Quebec (Target 35,000)
Date Projected daily maximum testing capacity
2020-09-03 20,000
2020-09-10 20,000
2020-09-17 20,000
2020-09-24 20,000
2020-10-01 20,000
2020-10-08 20,000
2020-10-15 20,000
2020-10-22 20,000
2020-10-29 20,000
2020-11-03 20,000
2020-11-10 20,000
2020-11-17 20,000
2020-11-24 20,000
2020-12-01 20,000
2020-12-08 35,199
2020-12-15 37,142
2020-12-22 38,846
2020-12-29 40,196
2021-01-05 37,972
2021-01-12 39,127
2021-01-19 36,929
2021-01-26 40,084
2021-02-02 40,977
2021-02-09 42,386
2021-02-16 39,497
2021-02-23 43,987
2021-03-02 41,386
2021-03-09 42,758
2021-03-16 42,427
2021-03-23 43,382
2021-03-29 44,037
2021-04-06 46,392
Ontario: Target 78,000
COVID-19 testing capacity for Ontario (Target 78,000)
Date Projected daily maximum testing capacity
2020-09-03 35,108
2020-09-10 39,690
2020-09-17 42,434
2020-09-24 42,816
2020-10-01 42,942
2020-10-08 50,692
2020-10-15 51,397
2020-10-22 64,340
2020-10-29 67,094
2020-11-03 71,564
2020-11-10 78,964
2020-11-17 80,856
2020-11-24 81,630
2020-12-01 81,630
2020-12-08 74,008
2020-12-15 77,333
2020-12-22 77,333
2020-12-29 77,581
2021-01-05 79,821
2021-01-12 120,608
2021-01-19 120,608
2021-01-26 120,608
2021-02-02 116,000
2021-02-09 116,000
2021-02-16 116,000
2021-02-23 116,000
2021-03-02 116,000
2021-03-09 117,800
2021-03-16 118,400
2021-03-23 118,400
2021-03-29 118,400
2021-04-06 120,200
Manitoba: Target 3,000
COVID-19 testing capacity for Manitoba (Target 3,000)
Date Projected daily maximum testing capacity
2020-09-03 3,000
2020-09-10 3,000
2020-09-17 3,000
2020-09-24 3,000
2020-10-01 3,000
2020-10-08 3,000
2020-10-15 3,000
2020-10-22 3,000
2020-10-29 3,000
2020-11-03 3,000
2020-11-10 3,000
2020-11-17 3,000
2020-11-24 3,000Footnote*
2020-12-01 2,841
2020-12-08 2,841Footnote*
2020-12-15 2,841Footnote*
2020-12-22 3,500
2020-12-29 3,500
2021-01-05 3,500
2021-01-12 3,500
2021-01-19 3,500
2021-01-26 3,500
2021-02-02 3,500
2021-02-09 3,500Footnote*
2021-02-16 3,500
2021-02-23 3,500
2021-03-02 3,500
2021-03-09 3,500Footnote*
2021-03-16 3,500
2021-03-23Footnote* 3,500
2021-03-29 3,500
2021-04-06 3,500*
Saskatchewan: Target 4,000
COVID-19 testing capacity for Saskatchewan (Target 4,000)
Date Projected daily maximum testing capacity
2020-09-03 1,800
2020-09-10 1,800
2020-09-17 1,800
2020-09-24 1,800
2020-10-01 1,800
2020-10-08 1,800
2020-10-15 1,800
2020-10-22 1,800
2020-10-29 1,800
2020-11-03 1,800
2020-11-10 2,100
2020-11-17 2,700
2020-11-24 2,700
2020-12-01 3,330
2020-12-08 3,450
2020-12-15 3,450
2020-12-22 3,450
2020-12-29 3,450
2021-01-05 3,846
2021-01-12 3,846
2021-01-19 3,846
2021-01-26 3,846
2021-02-02 3,846
2021-02-09 3,846Footnote*
2021-02-16 3,846Footnote*
2021-02-23 3,846
2021-03-02 3,846
2021-03-09 3,846
2021-03-16 4,000
2021-03-23 4,500
2021-03-29 4,500
2021-04-06 4,500
Alberta: Target 22,000
COVID-19 testing capacity for Alberta (Target 22,000)
Date Projected daily maximum testing capacity
2020-09-03 12,000
2020-09-10 12,000
2020-09-17 12,000
2020-09-24 12,000
2020-10-01 15,500
2020-10-08 22,000
2020-10-15 22,000
2020-10-22 22,000
2020-10-29 22,000
2020-11-03 22,000
2020-11-10 22,000
2020-11-17 22,000
2020-11-24 22,000
2020-12-01 22,000
2020-12-08 22,000Footnote*
2020-12-15 22,000
2020-12-22 22,000
2020-12-29 22,000
2021-01-05 22,000
2021-01-12 22,000
2021-01-19 22,000
2021-01-26 22,000
2021-02-02 22,000
2021-02-09 22,000
2021-02-16 22,000
2021-02-23 22,000
2021-03-02 22,000
2021-03-09 22,000
2021-03-16 22,000
2021-03-23 22,000
2021-03-29 22,000
2021-04-06 22,000
British Columbia: Target 20,000
COVID-19 testing capacity for British Columbia (Target 20,000)
Date Projected daily maximum testing capacity
2020-09-03 7,842
2020-09-10 8,581
2020-09-17 7,996
2020-09-24 9,633
2020-10-01 9,714
2020-10-08 10,506
2020-10-15 10,586
2020-10-22 12,840
2020-10-29 13,685
2020-11-03 17,033
2020-11-10 17,333
2020-11-17 18,733
2020-11-24 18,733
2020-12-01 18,733
2020-12-08 18,945
2020-12-15 18,945
2020-12-22 18,945
2020-12-29 18,945
2021-01-05 19,439
2021-01-12 19,439
2021-01-19 19,817
2021-01-26 19,817
2021-02-02 19,817
2021-02-09 19,817
2021-02-16 19,817
2021-02-23 20,617
2021-03-02 20,617
2021-03-09 20,617
2021-03-16 20,617
2021-03-23 21,332
2021-03-29 21,332
2021-04-06 19,932
Yukon: Target 160
COVID-19 testing capacity for Yukon (Target 160)
Date Projected daily maximum testing capacity
2020-09-03 n/a
2020-09-10 n/a
2020-09-17 n/a
2020-09-24 n/a
2020-10-01 150
2020-10-08 150
2020-10-15 150
2020-10-22 150
2020-10-29 150
2020-11-03 150
2020-11-10 150
2020-11-17 150
2020-11-24 150
2020-12-01 150Footnote*
2020-12-08 150Footnote*
2020-12-15 150
2020-12-22 150
2020-12-22 150
2020-12-29 150
2021-01-05 150
2021-01-12 150
2021-01-19 150
2021-01-26 150Footnote*
2021-02-02 150Footnote*
2021-02-09 150
2021-02-16 150Footnote*
2021-02-23 150Footnote*
2021-03-02 150
2021-03-09 150Footnote*
2021-03-16 150Footnote*
2021-03-23 150
2021-03-29 150
2021-04-06 150
Northwest Territories: Target 225
COVID-19 testing capacity for Northwest Territories (Target 225)
Date Projected daily maximum testing capacity
2020-09-03 n/a
2020-09-10 n/a
2020-09-17 n/a
2020-09-24 n/a
2020-10-01 48
2020-10-08 48
2020-10-15 48
2020-10-22 48
2020-10-29 75
2020-11-03 75
2020-11-10 75
2020-11-17 75
2020-11-24 75
2020-12-01 75Footnote*
2020-12-08 75Footnote*
2020-12-15 75Footnote*
2020-12-22 75
2020-12-29 75
2021-01-05 75
2021-01-12 75
2021-01-19 75
2021-01-26 75*
2021-02-02 110
2021-02-09 110
2021-02-16 110
2021-02-23 110
2021-03-02 110
2021-03-09 110
2021-03-16 110
2021-03-23 110
2021-03-29 110
2021-04-06 110
Nunavut: Target n/a
COVID-19 testing capacity for Nunavut (Target n/a)
Date Projected daily maximum testing capacity
2020-09-03 n/a
2020-09-10 n/a
2020-09-17 n/a
2020-09-24 n/a
2020-10-01 n/a
2020-10-08 n/a
2020-10-15 80
2020-10-22 80
2020-10-29 80
2020-11-03 100
2020-11-10 200
2020-11-17 200
2020-11-24 200
2020-12-01 200
2020-12-08 200
2020-12-15 250
2020-12-22 250
2020-12-29 250
2021-01-05 250
2021-01-12 250
2021-01-19 300
2021-01-26 300
2021-02-02 300
2021-02-09 300
2021-02-16 300
2021-02-23 300
2021-03-02 300
2021-03-09 300
2021-03-16 300
2021-03-23 300
2021-03-29 300
2021-04-06 300
Canada: Target 170,720 - 171,220
COVID-19 testing capacity for Canada (Target 170,720 - 171,220)
Date Projected daily maximum testing capacity
2020-09-03 84,550
2020-09-10 89,951
2020-09-17 92,030
2020-09-24 94,049
2020-10-01 82,504
2020-10-08 113,046
2020-10-15 113,911
2020-10-22 128,838
2020-10-29 132,234
2020-11-03 141,072
2020-11-10 149,172
2020-11-17 153,064
2020-11-24 154,838
2020-12-01 155,309
2020-12-08 163,218
2020-12-15 169,036
2020-12-22 171,399
2020-12-29 172,997
2021-01-05 174,103
2021-01-12 215,545
2021-01-19 213,775
2021-01-26 216,930
2021-02-02 213,350
2021-02-09 216,159
2021-02-16 213,270
2021-02-23 218,560
2021-03-02 215,959
2021-03-09 219,131
2021-03-16 219,599
2021-03-23 222,124
2021-03-29 222,779
2021-04-06 225,534

Related links

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: